About AIC-CCMB
AIC-CCMB, an accelerator and incubator program founded in 2017, is based in Hyderabad, India. With a presence in 6 countries, it has supported around 65 startups in sectors like Life Sciences, HealthTech. As of Oct 2026, AIC-CCMB has witnessed 1 portfolio exit. Most notable companies in
its portfolio include Huwel Life, Virupaksha Organics and Neuranics. The program is backed by a team of 26 people who primarily support Seed startups based in India. Its latest investment was a $44.3K Seed round in Consytel Life Sciences on Jan 16, 2026.
Key Metrics
Founded Year
2017
Location
Hyderabad, India
Portfolio Companies
Sectors of Investment
Stages of Investment
Seed & Grant (prize money)
AIC-CCMB's List of Top Investments
AIC-CCMB has a portfolio of 65 companies. Their most notable investments are in Consytel Life Sciences and Startoon Labs.Their portfolio spans across India, Austria, Germany and 3 more locations. They have invested in Life Sciences, HealthTech, High Tech and 10 other sectors, across stages such as Seed, Grant (prize money) stages. Here is the list of top investments by AIC-CCMB:
1. Huwel Life
Molecular diagnostic solutions and products for the healthcare industry. It offers a range of products and services, including custom oligonucleotide synthesis, molecular biology products like enzymes and reagents, and more. It develops DNA and RNA-based assays, recombinant enzymes, and the chemical synthesis of oligonucleotides.
Key facts about Huwel Life
- Founded Year: 2015
- Location: Hyderabad (India)
- Annual Revenue: ₹10 - ₹50 Cr as on Mar 31, 2025
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $5.74M
- Employee Count: 31 as on May 31, 2025
- Investors: BIRAC, AIC-CCMB and 3 Others
- Latest Funding Round: Series A, Sep 26, 2025, $*****
- Highlight: Editors' Pick
Manufacturer of high quality active pharmaceutical ingredients and intermediates. The company provides process support for pharmaceutical development and production, focusing on small molecule discovery and the creation of scalable chemical routes. It maintains a diversified portfolio and adheres to global regulatory standards for its manufacturing operations.
Key facts about Virupaksha Organics
- Founded Year: 2003
- Location: Hyderabad (India)
- Annual Revenue: ₹500 - ₹1,000 Cr as on Mar 31, 2025
- Valuation: $*****
- Stage: Series B
- Total Funding till date: $14.8M
- Employee Count: 1,206 as on May 31, 2026
- Investors: AIC-CCMB, Fkmanagements and 163 Others
- Latest Funding Round: Series B, Jul 18, 2024, $*****
3. Neuranics
Developer of magnetic sensing technology for next-generation wearable systems. The company uses magnetic sensing technology has potential applications in healthcare and can detect the magnetic fields generated by the muscles and the heart.
Key facts about Neuranics
- Founded Year: 2021
- Location: Glasgow (United Kingdom)
- Stage: Seed
- Total Funding till date: $10.3M
- Employee Count: 35 as on Aug 31, 2026
- Investors: Old College Capital, Creator Fund and 8 Others
- Latest Funding Round: Seed, Apr 09, 2025, $*****
- Highlight: Editors' Pick
Developer of medical device for physiotherapy assessment, monitoring, and reporting. The device tracks movement and generates reports to show progress during treatment. It offers a tool for physiotherapists to communicate patient recovery. The device monitors range of motion and surface EMG bio feedback.
Key facts about Startoon Labs
- Founded Year: 2017
- Location: Secunderabad (India)
- Annual Revenue: 0 - ₹10 Cr as on Mar 31, 2025
- Valuation: $*****
- Stage: Seed
- Total Funding till date: $465K
- Employee Count: 22 as on May 31, 2025
- Investors: IKP Knowledge Park, Guptaji invests and 14 Others
- Latest Funding Round: Seed, Apr 14, 2023, $*****
- Highlight: Editors' Pick
5. PopVax
Developer of mRNA platform for vaccines and therapeutics. It offers an open-source next-generation COVID-19 vaccine intended to broaden protection against both current and predicted future SARS-CoV-2 variants. It has a lipid nanoparticle (LNP) delivery platform for mRNA using PopVax-designed novel ionizable lipids and a machine learning-enabled computational approach.
Key facts about PopVax
- Founded Year: 2021
- Location: Hyderabad (India)
- Annual Revenue: ₹50 - ₹100 Cr as on Mar 31, 2025
- Stage: Funding Raised
- Employee Count: 79 as on Aug 31, 2025
- Investors: Medical Countermeasures, Gates and 1 Other
- Latest Funding Round: Grant (prize money), Sep 2025, $*****
AIC-CCMB's Year-on-Year Investment Trends
AIC-CCMB has invested in 65 companies over the last 5 years, with an average of 2 new investments annually in the last 5 years. As of Jan 2026, it has made 1 investment in this year. Its most recent first time investment was in Consytel Life Sciences and most recent follow-on round was in Caldor Health Technologies.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 0 | 1 |
2025 | 0 | 0 | 0 |
2024 | 0 | 1 | 1 |
2023 | 2 | 0 | 2 |
2022 | 5 | 1 | 6 |
2021 | 2 | 0 | 2 |
AIC-CCMB's Investments by Stage
AIC-CCMB has made 9 investments in Seed stage with an average round size of $97.5K and 1 investment in Grant (prize money) stage.Stage of entry | No. of Investments |
|---|---|
Seed | 9 |
Grant (prize money) | 1 |
Note: We have considered here, only first round of investments
AIC-CCMB's Investments by Sector
AIC-CCMB has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Enterprise Applications, HealthTech and Food and Agriculture Tech. Notably, it has invested in 47 Enterprise (B2B) companies, 42 Tech companies, 18 Tech hardware companies and at least 15 companies focusing on Software.Sector | No. of Investments |
|---|---|
Life Sciences | 7 |
High Tech | 4 |
Enterprise Applications | 3 |
HealthTech | 2 |
Food and Agriculture Tech | 1 |
Others | 4 |
Note: We have considered here, only first round of investments
AIC-CCMB's Investments by Geography
AIC-CCMB has made most investments in India (10).AIC-CCMB's recent investments
AIC-CCMB has made 1 investments in 2026 so far - Consytel Life Sciences.Here are the most recent investments by AIC-CCMB:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jan 16, 2026 | India | Seed | 6899 | - | |
Nov 01, 2024 | India | Seed | 7289 | ||
Mar 24, 2023 | India | Seed | 2515 | - | |
Feb 01, 2023 | India | Seed | 9079 | ||
Aug 31, 2022 | India | Seed | 5363 | - |
Acquired companies in AIC-CCMB's Portfolio
1 company from AIC-CCMB's portfolio has been acquired. The most recent acquisition was AVRA Laboratories in Jan 2022 by Advent International for $*****.Here are AIC-CCMB's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 24, 2022 | - | - | 2931 |
Team profile of AIC-CCMB
AIC-CCMB has a team of 26 members including 3 Partners and 3 Principals located in India. AIC-CCMB's team does not sit on the board of any company as of now.Here is a list of top team members in AIC-CCMB:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Hyderabad | - | ||
Partner | - | - | ||
Partner | Hyderabad | - | ||
Principal | - | - | - | |
Principal | Hyderabad | - | - | |
Principal | Hyderabad | - | - |
Co-investors of AIC-CCMB
Over the past 5 years, 77 investors have co-invested in AIC-CCMB's portfolio companies. This includes funds and angels.
- Invested before AIC-CCMB: Mohammed Suhail, Ravuri Niranjan and 12 others have invested in rounds before AIC-CCMB. There is 1 company where Mohammed Suhail has invested before AIC-CCMB and 1 company where Ravuri Niranjan has invested before AIC-CCMB.
- Top Co-investors of AIC-CCMB: 17 investors entered a company along with AIC-CCMB. These include investors like Sravan Kumar Narasipuram (1 company).
- Invested after AIC-CCMB: A total of 46 investors have invested in AIC-CCMB's portfolio after their investments. Top Investors include Guptaji invests (1 company) and IIT Indore (1 company).
